Maxona Pharmaceuticals, Inc.

CIK 1857448 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Maxona Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026D/A0001857448-26-000002
Jun 13, 2025D0001857448-25-000002
May 5, 2021D0001857448-21-000001